Latest News from Chordate Medical AB

Read our latest news and stories.

Read More
Read More
Read More
EU Patent Granted

Chordate Medical has been granted an EU patent covering a device for Autonomic Nervous System stimulation. We continue to strengthen our global IP…

Read More

Exploring new approach to neurostimulation

We're seeking to help patients with Non-Allergic Rhinitis with our novel treatment method KOS, Kinetic Oscillation Stimulation.

Large unmet medical need

Large unmet medical need

Chordate has a novel treatment technology with demonstrated effectiveness against clinically important health problems for which there are limited treatment options available today.

Medical device based technology

Medical device based technology

Our non-invasive technology is based on neurostimulation. It has no pharmaceutical or biological components.

Large potential market

Large potential market

Strong clinical results, ease of administration and improved quality of life are some of the factors that suggest a large potential market.